Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance.
Saved in:
| Title: | Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance. |
|---|---|
| Authors: | O'Shea, Leah K.1, Abdulkhalek, Samar1, Allison, Stephanie2, Neufeld, Ronald J.2, Szewczuk, Myron R.1 szewczuk@queensu.ca |
| Source: | OncoTargets & Therapy. 2014, Vol. 7, p117-134. 18p. |
| Database: | Academic Search Ultimate |
| ISSN: | 11786930 |
|---|---|
| DOI: | 10.2147/OTT.S55344 |
